Interleukin-1, interleukin-1 receptor antagonist and macrophage populations in rheumatoid arthritis synovial membrane
- PMID: 9376987
- DOI: 10.1093/rheumatology/36.9.935
Interleukin-1, interleukin-1 receptor antagonist and macrophage populations in rheumatoid arthritis synovial membrane
Abstract
To determine whether interleukin-1 (IL-1) and interleukin-1 receptor antagonist (IL-1ra) are produced by different macrophage subsets, we applied immunoperoxidase and double-labelling immunofluorescence techniques to 10 rheumatoid arthritis (RA) and 10 osteoarthritis (OA) synovial membranes. In RA, greater numbers of early 27E10+ macrophages were found in the sublining layer while mature 25F9+ macrophages were more abundant in the lining layers. The majority of IL-1alpha+ cells were also IL-1ra+ (79 +/- 12% sublining layer, 98 +/- 2% lining layer). In OA sublining layer, a higher percentage of cells double stained for 25F9 and IL-1ra was detected compared to those double stained for 25F9 and IL-1alpha (P < 0.004). In OA, 25F9+ macrophages demonstrated a lower percentage of IL-1alpha+ in the lining and sublining layers compared to RA (P < 0.02 and P < 0.004, respectively). It may be concluded that once monocytes have migrated into the RA joint, they undergo phenotypic and functional changes from an early profile (27E10+, CD14+, low percentage of IL-1+ and IL-1ra+ cells) to a mature profile (CD14+/-, 25F9+, RM3/1+, high percentage of IL-1+ and IL-1ra+ cells).
Similar articles
-
Localization of interleukin-1 alpha, type 1 interleukin-1 receptor and interleukin-1 receptor antagonist in the synovial membrane and cartilage/pannus junction in rheumatoid arthritis.Br J Rheumatol. 1992 Dec;31(12):801-9. doi: 10.1093/rheumatology/31.12.801. Br J Rheumatol. 1992. PMID: 1458286
-
Inhomogeneity of immune cell composition in the synovial sublining: linear mixed modelling indicates differences in distribution and spatial decline of CD68+ macrophages in osteoarthritis and rheumatoid arthritis.Arthritis Res Ther. 2016 Jul 16;18:170. doi: 10.1186/s13075-016-1057-3. Arthritis Res Ther. 2016. PMID: 27424032 Free PMC article.
-
Interleukin-1 receptor antagonist production in cultured synovial cells from patients with rheumatoid arthritis and osteoarthritis.Ann Rheum Dis. 1995 Apr;54(4):318-20. doi: 10.1136/ard.54.4.318. Ann Rheum Dis. 1995. PMID: 7763113 Free PMC article.
-
[Macrophages in rheumatoid synovial membrane: an update].Rev Rhum Ed Fr. 1993 Oct;60(9):568-79. Rev Rhum Ed Fr. 1993. PMID: 8012331 Review. French.
-
[IL-1Ra: its role in rheumatoid arthritis].Reumatismo. 2004 Jan-Mar;56(1 Suppl 1):41-5. doi: 10.4081/reumatismo.2004.1s.41. Reumatismo. 2004. PMID: 15201939 Review. Italian.
Cited by
-
Driving chronicity in rheumatoid arthritis: perpetuating role of myeloid cells.Clin Exp Immunol. 2018 Jul;193(1):13-23. doi: 10.1111/cei.13098. Epub 2018 Feb 2. Clin Exp Immunol. 2018. PMID: 29315512 Free PMC article. Review.
-
Folate Receptor β (FRβ) Expression in Tissue-Resident and Tumor-Associated Macrophages Associates with and Depends on the Expression of PU.1.Cells. 2020 Jun 10;9(6):1445. doi: 10.3390/cells9061445. Cells. 2020. PMID: 32532019 Free PMC article.
-
Optimization of Folate-Targeted Immunotherapy for the Treatment of Experimental Arthritis.Inflammation. 2016 Aug;39(4):1345-53. doi: 10.1007/s10753-016-0366-7. Inflammation. 2016. PMID: 27206918
-
Synovial cellular and molecular markers in rheumatoid arthritis.Semin Immunopathol. 2017 Jun;39(4):385-393. doi: 10.1007/s00281-017-0631-3. Epub 2017 May 11. Semin Immunopathol. 2017. PMID: 28497350 Free PMC article. Review.
-
Immunomodulatory matrix-bound nanovesicles mitigate acute and chronic pristane-induced rheumatoid arthritis.NPJ Regen Med. 2022 Feb 2;7(1):13. doi: 10.1038/s41536-022-00208-9. NPJ Regen Med. 2022. PMID: 35110573 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials